To investigate whether exogenous IL-33 affects HCC occurrence by regulating the immune system, we examined immune cell phenotypes in the spleen and tumours of Hepa1-6-bearing mice treated with IL-33 and those who were not (Fig. 3). Here, IL33 is linked to neoplasm.